NASHVILLE, September 2, 2026, 11:50 EDT —
- HCA eliminated a “small percentage” of roles in its corporate office and support divisions.
- Shares declined by 0.51% to $411.46 as of 11:49 EDT.
- HCA anticipates an exchange-related earnings headwind of between $1.0 billion and $1.2 billion in 2026.
Shares of HCA Healthcare NYSE:HCA fell 0.51% following new rounds of corporate layoffs. The hospital operator was trading at $411.46 as of 11:49 EDT Yahoo Finance.
The reductions provide a way to manage overhead following softer earnings forecasts. However, HCA did not specify workforce numbers or anticipated cost reductions. This leaves the policy-driven revenue gap as the more significant factor in valuation.
Based on guidance midpoints, exchange losses surpass Medicaid benefits by approximately $700 million. This amount represents 4.4% of HCA’s updated adjusted EBITDA midpoint. This figure is illustrative and does not reflect company guidance.
HCA shares recovered from the opening low
NYSE price in U.S. dollars; previous close $413.58
HCA reported cutting a “small percentage” of positions at its corporate office and in support functions. The company described the move as a difficult decision WKRN via Yahoo Finance.
A local report also verified the Tuesday job cuts Nashville Business Journal. HCA has not detailed severance expenses, specified which units are impacted, or outlined the timeline. This leaves investors unable to estimate the projected cost savings.
Revenue growth outran profit growth
Second-quarter 2026 year-on-year change; bars share a 0%–12% scale
Revenue for the second quarter increased by 8.7% to $20.23 billion. Adjusted EBITDA was up 4.6% to $4.03 billion HCA results. Operating profit did not keep pace with sales growth.
Care volumes presented a mixed picture. Same-facility admissions increased by 2.5%, and emergency department visits were up 3.6%. Inpatient surgeries declined 2.3%, with outpatient surgeries down 3.4%.
HCA lowered its 2026 adjusted EBITDA guidance to $15.4 billion–$16.1 billion, down from the earlier range of $15.55 billion–$16.45 billion. The midpoint for earnings per share decreased by 2.3% to $29.60.
The policy gap dwarfs unquantified layoff savings
HCA’s revised 2026 assumptions; midpoint arithmetic in U.S. dollars
The exchange dragged earnings by $400 million in the second quarter, HCA said, citing a rise in uninsured patients. Medicaid reimbursements offered an offset of about the same amount for that period.
Cash flow presents an additional limitation. Operating cash flow declined to $2.34 billion from $4.21 billion. HCA nevertheless allocated $2.06 billion to buy back 4.75 million shares.
Shares of other hospital companies also moved lower. Tenet Healthcare NYSE:THC was down 1.0% at 11:42 EDT. Universal Health Services NYSE:UHS slipped 0.34% THC; UHS.
Risks: Reductions in support roles could deliver cost savings more quickly than the market anticipates, but may also disrupt billing, technology, or compliance operations. HCA has not put figures on either potential effect.
The upcoming shareholder record date is September 16. Shareholders as of that date are set to get the $0.78 quarterly dividend on September 30. Investors are expected to monitor for any layoff-related charges and updated cost goals ahead of the next earnings announcement.
Related articles: Stock Market
